DASH Prediction Score for Recurrent VTE

Stratifies annual recurrence risk after a first unprovoked VTE to help decide whether anticoagulation can be stopped or should continue after the initial treatment course; validated for unprovoked VTE only, and the hormonal-therapy point applies to women.